Outlook Therapeutics, Inc. balance sheet

At the end of fiscal 2025, Outlook Therapeutics, Inc. had total assets of $18.6m, total liabilities of $50.8m and shareholders' equity of −$32.2m. It held $8.1m in cash against $29.9m of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Outlook Therapeutics, Inc.: balance sheet, annual
Fiscal year	2015Sept 2015	2016Sept 2016	2017Sept 2017	2018Sept 2018	2019Sept 2019	2025Sept 2025
Cash and equivalents	9	2	3	2	8	8
Receivables	0	—	—	—	—	1
Inventory	—	—	—	—	—	3
Total current assets	15	6	4	3	14	17
Total assets	35	25	21	22	17	19
Accounts payable	12	5	11	4	2	10
Deferred revenue (current)	2	1	3	2	—	—
Total current liabilities	37	20	29	32	20	46
Short-term debt	1	1	0	0	1,026	—
Long-term debt	3	2	0	0	50	—
Total debt	17	7	5	5	1,076	30
Total liabilities	63	31	51	43	28	51
Shareholders' equity	−54	−5	−34	−26	−16	−32
Non-controlling interests and other (assets − liabilities − equity)	27	—	3	5	5	—

US$ millions unless shown otherwise. Fiscal quarters.

Outlook Therapeutics, Inc.: balance sheet, quarterly
Quarter	2018 Q3Jun 2018	2018 Q4Sept 2018	2019 Q1Dec 2018	2019 Q2Mar 2019	2019 Q3Jun 2019	2019 Q4Sept 2019	2025 Q3Jun 2025	2025 Q4Sept 2025
Receivables	—	—	—	—	—	—	2	1
Inventory	—	—	—	—	—	—	4	3
Total current assets	13	3	2	2	19	14	21	17
Total assets	34	22	19	17	33	17	22	19
Accounts payable	3	4	5	5	3	2	10	10
Deferred revenue (current)	2	2	2	2	2	—	—	—
Total current liabilities	32	32	28	27	23	20	31	46
Short-term debt	0	0	0	1	1	1,026	—	—
Long-term debt	0	0	0	0	0	50	—	—
Total debt	0	0	0	1	1	1,076	—	—
Total liabilities	43	43	40	40	35	28	60	51
Shareholders' equity	−13	−26	−26	−28	−7	−16	−37	−32
Non-controlling interests and other (assets − liabilities − equity)	4	5	5	5	5	5	—	—
Shares outstanding	72m	9m	85m	12m	28m	29m	43m	54m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ACRS vs OTLK COYA vs OTLK APLM vs OTLK

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Outlook Therapeutics, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Outlook Therapeutics, Inc.